Literature DB >> 26789657

The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts.

Zeljka Korade1, Hye-Young H Kim, Keri A Tallman, Wei Liu, Katalin Koczok2, Istvan Balogh2, Libin Xu, Karoly Mirnics1, Ned A Porter1.   

Abstract

Well-established cell culture models were combined with new analytical methods to assess the effects of small molecules on the cholesterol biosynthesis pathway. The analytical protocol, which is based on sterol derivation with the dienolphile PTAD, was found to be reliable for the analysis of 7-DHC and desmosterol. The PTAD method was applied to the screening of a small library of pharmacologically active substances, and the effect of compounds on the cholesterol pathway was determined. Of some 727 compounds, over 30 compounds decreased 7-DHC in Dhcr7-deficient Neuro2a cells. The examination of chemical structures of active molecules in the screen grouped the compounds into distinct categories. In addition to statins, our screen found that SERMs, antifungals, and several antipsychotic medications reduced levels of 7-DHC. The activities of selected compounds were verified in human fibroblasts derived from Smith-Lemli-Opitz syndrome (SLOS) patients and linked to specific transformations in the cholesterol biosynthesis pathway.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26789657      PMCID: PMC4838819          DOI: 10.1021/acs.jmedchem.5b01696

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  78 in total

Review 1.  The ins and outs of cholesterol in the vertebrate retina.

Authors:  Steven J Fliesler; Lionel Bretillon
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

2.  DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model.

Authors:  Libin Xu; Karoly Mirnics; Aaron B Bowman; Wei Liu; Jennifer Da; Ned A Porter; Zeljka Korade
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

3.  Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome.

Authors:  Patricia Hall; Virginia Michels; Dimitar Gavrilov; Dietrich Matern; Devin Oglesbee; Kimiyo Raymond; Piero Rinaldo; Silvia Tortorelli
Journal:  Mol Genet Metab       Date:  2013-04-10       Impact factor: 4.797

4.  Cholesterol and cognition in schizophrenia: a double-blind study of patients randomized to clozapine, olanzapine and haloperidol.

Authors:  Menahem Krakowski; Pal Czobor
Journal:  Schizophr Res       Date:  2011-05-06       Impact factor: 4.939

5.  Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome.

Authors:  G S Tint; M Seller; R Hughes-Benzie; A K Batta; S Shefer; D Genest; M Irons; E Elias; G Salen
Journal:  J Lipid Res       Date:  1995-01       Impact factor: 5.922

Review 6.  What can be learned from the levormeloxifene experience?

Authors:  Pernille Ravn; Therese F Nielsen; Claus Christiansen
Journal:  Acta Obstet Gynecol Scand       Date:  2006       Impact factor: 3.636

7.  Concerning the reactivity of PTAD with isomeric dienes: the mechanism of the Diels-Alder cycloaddition.

Authors:  Mariza N Alberti; Michael Orfanopoulos
Journal:  Org Lett       Date:  2009-04-02       Impact factor: 6.005

8.  In vivo blockade of the estradiol-binding-protein (EBP) by clomiphene citrate in human breast cancer.

Authors:  R Garola; C M Levy; I Vegh; C Magin; J C Martinez; E Hecker
Journal:  Oncology       Date:  1974       Impact factor: 2.935

9.  Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome.

Authors:  Yen-Ming Chan; Louise S Merkens; William E Connor; Jean-Baptiste Roullet; Jennifer A Penfield; Julia M Jordan; Robert D Steiner; Peter J H Jones
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

10.  FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.

Authors:  Lisa M Johansen; Jennifer M Brannan; Sue E Delos; Charles J Shoemaker; Andrea Stossel; Calli Lear; Benjamin G Hoffstrom; Lisa Evans Dewald; Kathryn L Schornberg; Corinne Scully; Joseph Lehár; Lisa E Hensley; Judith M White; Gene G Olinger
Journal:  Sci Transl Med       Date:  2013-06-19       Impact factor: 17.956

View more
  26 in total

1.  Identification of Environmental Quaternary Ammonium Compounds as Direct Inhibitors of Cholesterol Biosynthesis.

Authors:  Josi Herron; Rosalyn C Reese; Keri A Tallman; Rohini Narayanaswamy; Ned A Porter; Libin Xu
Journal:  Toxicol Sci       Date:  2016-02-26       Impact factor: 4.849

2.  Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity.

Authors:  Elijah J Weber; Kevin A Lidberg; Lu Wang; Theo K Bammler; James W MacDonald; Mavis J Li; Michelle Redhair; William M Atkins; Cecilia Tran; Kelly M Hines; Josi Herron; Libin Xu; Maria Beatriz Monteiro; Susanne Ramm; Vishal Vaidya; Martti Vaara; Timo Vaara; Jonathan Himmelfarb; Edward J Kelly
Journal:  JCI Insight       Date:  2018-12-20

3.  Diverse Chemical Scaffolds Enhance Oligodendrocyte Formation by Inhibiting CYP51, TM7SF2, or EBP.

Authors:  Dharmaraja Allimuthu; Zita Hubler; Fadi J Najm; Hong Tang; Ilya Bederman; William Seibel; Paul J Tesar; Drew J Adams
Journal:  Cell Chem Biol       Date:  2019-02-14       Impact factor: 8.116

4.  Propagation rate constants for the peroxidation of sterols on the biosynthetic pathway to cholesterol.

Authors:  Connor R Lamberson; Hubert Muchalski; Kari B McDuffee; Keri A Tallman; Libin Xu; Ned A Porter
Journal:  Chem Phys Lipids       Date:  2017-02-05       Impact factor: 3.329

5.  Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors.

Authors:  Kelsey A Rankin; Feng Mei; Kicheol Kim; Yun-An A Shen; Sonia R Mayoral; Caroline Desponts; Daniel S Lorrain; Ari J Green; Sergio E Baranzini; Jonah R Chan; Riley Bove
Journal:  J Neurosci       Date:  2019-01-29       Impact factor: 6.167

6.  Assessment of Altered Cholesterol Homeostasis by Xenobiotics Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Josi Herron; Kelly M Hines; Libin Xu
Journal:  Curr Protoc Toxicol       Date:  2018-10-15

7.  7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD).

Authors:  Shuan Shian Huang; I-Hua Liu; Chun-Lin Chen; Jia-Ming Chang; Frank E Johnson; Jung San Huang
Journal:  J Cell Biochem       Date:  2016-12-13       Impact factor: 4.429

8.  Inhibitors of 7-Dehydrocholesterol Reductase: Screening of a Collection of Pharmacologically Active Compounds in Neuro2a Cells.

Authors:  Hye-Young H Kim; Zeljka Korade; Keri A Tallman; Wei Liu; C David Weaver; Karoly Mirnics; Ned A Porter
Journal:  Chem Res Toxicol       Date:  2016-04-28       Impact factor: 3.739

9.  Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol.

Authors:  Phillip A Wages; Hye-Young H Kim; Zeljka Korade; Ned A Porter
Journal:  J Lipid Res       Date:  2018-08-07       Impact factor: 5.922

10.  Vulnerability of DHCR7+/- mutation carriers to aripiprazole and trazodone exposure.

Authors:  Zeljka Korade; Thiago C Genaro-Mattos; Keri A Tallman; Wei Liu; Krassimira A Garbett; Katalin Koczok; Istvan Balogh; Karoly Mirnics; Ned A Porter
Journal:  J Lipid Res       Date:  2017-09-28       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.